What is Rocatan (potential medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Rocatan?

Based on the available evidence, there is no medication called "Rocatan" in current clinical use. You may be referring to one of several similarly-named medications that exist in different therapeutic areas.

Possible Medications You May Be Asking About:

Rocatinlimab (Most Likely Match)

  • Rocatinlimab is a novel T-cell rebalancing therapy that targets the OX40 receptor for treatment of moderate-to-severe atopic dermatitis 1
  • This monoclonal antibody works by inhibiting and reducing pathogenic T cells through OX40 receptor blockade, which is specifically expressed on activated T cells 1
  • The mechanism addresses the underlying T-cell imbalance that drives chronic inflammation in atopic dermatitis 1

Clinical Development Status:

  • Currently in Phase 3 clinical trials through the ROCKET program, which includes eight global studies evaluating efficacy and safety in adults and adolescents with moderate-to-severe AD 2, 1
  • Phase 2b trial data showed significant improvements in disease severity, skin involvement, pruritus, sleep disturbance, and quality of life compared to placebo at week 16 1
  • Notably demonstrated durable responses that were maintained during a 20-week off-treatment period in responders, suggesting potential for disease modification 1
  • Has shown a favorable safety and tolerability profile in trials to date 1

Valoctocogene Roxaparvovec (ROCTAVIAN)

  • This is an AAV-based gene therapy approved for hemophilia A, not a traditional medication 3
  • Uses recombinant adeno-associated virus vectors to transfer functional F8 genetic information into hepatocytes for endogenous Factor VIII production 3
  • Administered as a single IV infusion with the goal of providing long-term symptomatic relief 3

Important hepatotoxicity considerations:

  • Requires careful liver health assessment before administration due to potential immune-mediated hepatotoxicity 3
  • Contraindicated in patients with significant liver fibrosis (stage 3 or 4 on Batts-Ludwig scale) 3
  • Requires collaboration with hepatology specialists for patient eligibility assessment 3

Clinical Caveat:

If you intended to ask about a different medication, please verify the exact spelling, as medication names can be easily confused and prescribing the wrong agent could have serious clinical consequences.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.